Photo taken from Angela Toss/X
May 19, 2024, 08:14
Angela Toss: Exploratory analysis of BRCA mutations in the MonarchE trial.
Angela Toss, Assistant Professor in the Unit of Genetic Oncology of the Department of Medical and Surgical Sciences at the University of Modena and Reggio Emilia, shared a post on LinkedIn:
“Exploratory analysis of BRCA mutations in the MonarchE trial:
3.5% gBRCA1/2+ (lower than expected)
abema benefit in gBRCA, but not in sBRCA2 and RB1
caution for small sample size
Do CDK4/6i perform differently in gBRCA early BC patients compared to advanced disease?”
Source: Angela Toss/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 09:55
Nov 21, 2024, 09:28
Nov 21, 2024, 09:23
Nov 21, 2024, 09:04
Nov 21, 2024, 06:49